ÖGRO-Preisträger bis 2012

1. Preis   

Dr. Maximilian P. Schmid

Late gastrointestinal and urogenital side-effects after radiotherapy - Incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer.

2. Preis   

Prof. Dr. Frank Wolf, PhD

Novel luciferase-based reporter system to monitor activation of ErbB2/Her2/neu pathway noninvasively during radiotherapy

2. Preis

Dr. Carola Lütgendorf-Caucig, MPH, MBA

Multi-center evaluation of different target volume delineation concepts in Paediatric Hodgkin's Lymphoma: a case study

1. Preis    

Mag. Heinz Deutschmann

First Clinical Release of an Online, Adaptive, Aperture-Based Image-Guided Radiotherapy Strategy in Intensity-Modulated Radiotherapy to Correct for Inter- and Intrafractional Rotations of the Prostate.

1. Preis    

Prof. Dr. Petra Georg, MBA

Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.

2. Preis     

Dr. Daniela Kauer-Dorner

Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: Alternative to mastectomy? Results from a prospective trial.

2. Preis     

Dr. Gabriela Altorjai

Cone-Beam CT-Based Delineation of Stereotactic Lung Targets: The Influence of Image Modality and Target Size on Interobserver Variability.

1. Preis   

Dr. Ira Skvortsova

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement ofsquamous cell carcinoma radioresponse.

2. Preis     

Prof. Dr. Petra Georg, MBA

Dose-Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image-Guided Adaptive Cervical CancerBrachytherapyDose-Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image-Guided Adaptive Cervical Cancer Brachytherapy.

2. Preis    

Dr. Karl Wurstbauer

Non-Small Cell Lung Cancer in Stages I – IIIB.

2. Preis     

Mag. Dr. Brigitte Zurl

Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with Deep-Inspiration-Breath-Hold (DIBH).

1. Preis    

Dr. Ira Skvortsova

Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells."
1. PREIS    Olaf Nairz et al / "A Strategy for the Use of Image-Guided Radiotherapy (IGRT) on Linear Accelerators and its Impact on Treatment Margins for Prostate Cancer Patients

2. Preis  

Dr. Elisabeth Bräutigam

Medial tumour localisation in breast cancer - an unappreciated risk factor?

2. Preis    

Dr. Karl Wurstbauer

Nonresected Non–Small-Cell Lung Cancer in Stages I through IIIB: Accelerated, Twice-Daily, High-Dose Radiotherapy — A Prospective Phase I/II Trial with Long-Term Follow-Up

1. Preis  

Dr. Karl Wurstbauer

NSCLC: Primary Tumor Size – Radiation Dose-related Accelerated, Twice Daily Radiotherapy by Target Splitting, Preceded by 2 Cycles of Chemotherapy – First Results of a Prospective Study.

2. Preis   

Mag. Heinz Deutschmann

"Augmented Reality” in Conventional Simulation by Projection of 3-D Structures into 2-D Images - A Comparison with Virtual Methods.

1. Preis  

Dr. Tanja Langsenlehner

Long-Term Follow-up of Patients with Pituitary Macroadenomas after Postoperative Radiation Therapy.

2. Preis  

Prof. Dr. Gregor Goldner

Long-Term Results in Three-Dimensional Conformal Radiotherapy of Localized Prostate Cancer at Moderate Dose (66 Gy).

1. Preis     

Johannes C. A. Dimopoulos, M.D.

The Vienna Applicator for combined Intracavitary and Interstitial Brachytherapy of Cervical Cancer: Clinical Feasibility and preliminary Results.

1. Preis    

Prof. Dr. Gregor Goldner

Proctitis after external beam radiotherapy for prostate cancer classified by the “Vienna Rectoscopy Score” and correlated to the EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study in 166 patients.

1. Preis  

Dr. Hajo Dirk Weitmann

Pilot study in the treatment of endometrial carcinoma with 3D image-based HDR brachytherapy using modified Heymannpacking: Clinical experience and dose volume histogram analysis.

2. Preis     

Dr. Karl Wurstbauer

Radiotherapy planning for lung cancer: Slow CTs allow the drawing of tighter margins.

2. Preis   

Dr. Ira Skvortsova

Pretreatment with Rituximab enhances radiosensitivity of non-Hodgkin’s lymphoma cells.

2. Preis    

Prof. Dr. Günter Gruber

Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical Cyclophosphamide, Methotrexate, and Fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.

1. Preis   

Prof. Dr. Meinhard Nevinny-Stickel

Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vaccuum technique.

1. Preis     

Prof. Dr. Heidi Stranzl

Extracapsular extension in positive axillary lymph nodes in feale breast cancer patients.

1. Preis     

Dr. Ulrike Mock

2. Preis    

Prof. Dr. Oliver Micke

„Predictive Value of Carbohydrate Antigen 19-9 in Pancreatic Cancer treated with Radiochemotherapy.“

1. Preis      

Dr. Alfred Haidenberger

Influence of Fractionated Irradiation on Neutrophilic Granulocyte Function.

1. Preis   

Prof. Dr. Boris Pokrajac

Intraarterial 192-Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminalangioplasty: The prospective randomized Vienna-2-Trial radiotherapy parameters and risk factors analysis.

2. Preis    

Prof. Dr. Meinhard Nevinny-Stickel

Comparison of standard and individually planned infradiaphragmatic fields in irradiation of retroperitoneal lymph nodes.
 

1. Preis     

Prim. Univ.-Doz. Dr. Alexander de Vries

Monitoring of tumor microcirculation during fractionated radiotherapy in patients with rectal carcinoma: preliminiaryresults and possible implications for therapy.

1. Preis   

Dr. Karl Wurstbauer

Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.